Insights
Top 10 Regulatory Experts Supporting FDA Submission Success
Life sciences organizations are under pressure to move faster, advancing new programs, entering global markets, and meeting increasingly stringent regulatory expectations. We often see teams
Supplier Qualification and Oversight in Pharma
In the biotech, pharmaceutical, and life sciences industries, internal and supplier audits are crucial for identifying compliance risks before they escalate into regulatory or operational
FDA BLA Submissions: Strategic Planning
Life sciences programs face evolving regulatory risks at every stage from preclinical IND filings to global CTA submissions and through NDA or BLA approvals. We
Biologics License Applications: Ensuring Complete Clinical, CMC, and Regulatory Readiness
Life sciences programs face evolving regulatory risks at every stage from preclinical IND filings to global CTA submissions and through NDA or BLA approvals. We
GMP Inspection Readiness: Checklist for Pharma and Biotech
For life sciences organizations, FDA inspections are high-stakes events that test every aspect of operations, from documentation and processes to staff readiness. Mock FDA audits
How Pharma Companies Can Develop Effective Remediation Plans
For medical device companies seeking to conduct clinical trials in the United States, an Investigational Device Exemption (IDE) application is essential. A well-prepared IDE submission